CN112602861A - Basidiomycetes composite beverage for improving immunity and preparation method thereof - Google Patents
Basidiomycetes composite beverage for improving immunity and preparation method thereof Download PDFInfo
- Publication number
- CN112602861A CN112602861A CN202011458352.3A CN202011458352A CN112602861A CN 112602861 A CN112602861 A CN 112602861A CN 202011458352 A CN202011458352 A CN 202011458352A CN 112602861 A CN112602861 A CN 112602861A
- Authority
- CN
- China
- Prior art keywords
- parts
- basidiomycete
- powder
- beverage
- freeze
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000221198 Basidiomycota Species 0.000 title claims abstract description 53
- 235000013361 beverage Nutrition 0.000 title claims abstract description 38
- 230000036039 immunity Effects 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 239000002131 composite material Substances 0.000 title claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 65
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 42
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 41
- 239000000796 flavoring agent Substances 0.000 claims abstract description 26
- 244000131360 Morinda citrifolia Species 0.000 claims abstract description 24
- 235000017524 noni Nutrition 0.000 claims abstract description 24
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 22
- 235000014360 Punica granatum Nutrition 0.000 claims abstract description 22
- 239000000284 extract Substances 0.000 claims abstract description 22
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 21
- 244000000626 Daucus carota Species 0.000 claims abstract description 21
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 21
- 150000001875 compounds Chemical class 0.000 claims abstract description 21
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 21
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 claims abstract description 20
- 240000003394 Malpighia glabra Species 0.000 claims abstract description 20
- 235000014837 Malpighia glabra Nutrition 0.000 claims abstract description 20
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 20
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 20
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 16
- 235000013355 food flavoring agent Nutrition 0.000 claims abstract description 16
- 235000013305 food Nutrition 0.000 claims abstract description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 62
- 241000219991 Lythraceae Species 0.000 claims description 21
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 19
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 235000019634 flavors Nutrition 0.000 claims description 10
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- 239000001630 malic acid Substances 0.000 claims description 9
- 235000011090 malic acid Nutrition 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 26
- 230000000875 corresponding effect Effects 0.000 abstract description 14
- 230000006870 function Effects 0.000 abstract description 14
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 206010028980 Neoplasm Diseases 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 8
- 210000000987 immune system Anatomy 0.000 abstract description 8
- 230000003647 oxidation Effects 0.000 abstract description 7
- 238000007254 oxidation reaction Methods 0.000 abstract description 7
- 241000700605 Viruses Species 0.000 abstract description 5
- 210000004072 lung Anatomy 0.000 abstract description 5
- 230000001363 autoimmune Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 230000028327 secretion Effects 0.000 abstract description 4
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 210000001124 body fluid Anatomy 0.000 abstract description 3
- 239000010839 body fluid Substances 0.000 abstract description 3
- 230000001413 cellular effect Effects 0.000 abstract description 3
- 230000005934 immune activation Effects 0.000 abstract description 3
- 210000003296 saliva Anatomy 0.000 abstract description 3
- 238000012859 sterile filling Methods 0.000 abstract description 3
- 244000294611 Punica granatum Species 0.000 abstract 1
- 230000001276 controlling effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 25
- 229960004106 citric acid Drugs 0.000 description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 11
- 235000019640 taste Nutrition 0.000 description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 8
- 229930003268 Vitamin C Natural products 0.000 description 8
- 235000019154 vitamin C Nutrition 0.000 description 8
- 239000011718 vitamin C Substances 0.000 description 8
- 230000032683 aging Effects 0.000 description 7
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 5
- 150000001746 carotenes Chemical class 0.000 description 5
- 235000005473 carotenes Nutrition 0.000 description 5
- 230000036737 immune function Effects 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 5
- 241000208340 Araliaceae Species 0.000 description 4
- 229920001503 Glucan Polymers 0.000 description 4
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 229960003987 melatonin Drugs 0.000 description 4
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 4
- 210000004560 pineal gland Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 235000019614 sour taste Nutrition 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000167854 Bourreria succulenta Species 0.000 description 2
- 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 235000019693 cherries Nutrition 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 239000002955 immunomodulating agent Substances 0.000 description 2
- 229940121354 immunomodulator Drugs 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- QWQWBHZHRMHXOC-UHFFFAOYSA-N 7-Hydroxy-6-methyl-2H-1-benzopyran-2-one Chemical compound C1=CC(=O)OC2=C1C=C(C)C(O)=C2 QWQWBHZHRMHXOC-UHFFFAOYSA-N 0.000 description 1
- 244000251953 Agaricus brunnescens Species 0.000 description 1
- 229920000310 Alpha glucan Polymers 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 208000030814 Eating disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- 208000019454 Feeding and Eating disease Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 101000588302 Homo sapiens Nuclear factor erythroid 2-related factor 2 Proteins 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 241001506304 Kadsura japonica Species 0.000 description 1
- 235000008898 Morinda citrifolia Nutrition 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 102100031701 Nuclear factor erythroid 2-related factor 2 Human genes 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010044248 Toxic shock syndrome Diseases 0.000 description 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 235000013574 canned fruits Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000036570 collagen biosynthesis Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000014632 disordered eating Nutrition 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229960002413 ferric citrate Drugs 0.000 description 1
- 229910001447 ferric ion Inorganic materials 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000011502 immune monitoring Methods 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000008433 psychological processes and functions Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000022983 regulation of cell cycle Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention belongs to the technical field of health-care food, and discloses a basidiomycete compound beverage for improving immunity and a preparation method thereof. The composite beverage is based on cellular immunology as a scientific theory, and is matched with basidiomycete freeze-dried powder with an immune activation effect, red ginseng extract with functions of greatly invigorating primordial qi, benefiting qi and controlling blood, fine yellow powder with functions of moistening lung and promoting the secretion of saliva or body fluid and other traditional Chinese medicine extracts with corresponding effects, acerola powder, fructo-oligosaccharide, red pomegranate concentrated juice, carrot concentrated juice, noni pulp, gamma-aminobutyric acid, a sour agent and a flavoring agent, so that the preparation which can quickly regulate and activate the activity of autoimmune cells from a cell level, regulate an immune system, improve immunity, resist tumors, resist viruses, reduce blood sugar, resist oxidation, is easy to absorb, enhances physique and is beneficial to sleep is obtained. In the preparation process of the compound beverage, an advanced pharmaceutical grade BFS sterile filling production process and production equipment are adopted, and the activity and effectiveness of various effective active ingredients are ensured.
Description
Technical Field
The invention belongs to the technical field of health-care food, and particularly relates to a basidiomycete compound beverage for improving immunity and a preparation method thereof.
Background
The immune system plays a main role in physiological defense, self-stabilization and immune monitoring in the human body, and is the most important defense system for the human body to resist pathogenic bacteria invasion. Once the immune function is low, the infection of bacteria, virus and fungi is very easy to be caused, and the most direct manifestation is that the disease is easy to occur. Research proves that the low immunity of the current society is mainly concentrated on three groups of people: firstly, the disease population, especially tumor and cancer patients, suffer from impaired cellular immunity and humoral immunity due to radiotherapy, chemotherapy and large-dose use of antibiotics, so that the improvement of the body constitution and the immune function, the alleviation of the toxic and side effects of chemotherapy, the enhancement of the curative effect, the prolongation of the postoperative life cycle and the improvement of the life quality are very important for the tumor patients. Secondly, people who have irregular life, eating disorder, lack of exercise and great psychological and mental stress can not normally play a role in protecting the immune system induced by various factors. Thirdly, infants and old people, the immune system of infants is not mature, the IgG antibody obtained from the mother body disappears, so the infants and old people are easy to infect, and the old people suffer from thymus atrophy, the reduction of the number and the function of immune cells to cause the reduction of specific and non-specific immunity, and are also easy to cause infectious diseases and malignant tumors.
According to survey, the proportion of people with low immunity is rising year by year, and products for improving immunity in the current market are all eight-flower, such as immunomodulators, health products for improving immunity and the like, but have certain problems. The immunomodulator has side effects on human body, and can generate drug resistance after being taken for a long time; the health care product for improving the immunity is approved by the national food and drug administration to be more than one thousand, and although the variety is various, the problems of slow effect, low absorption performance, unobvious effect and side effect generally exist.
Disclosure of Invention
In order to solve the problems in the prior art, the invention aims to provide a basidiomycete composite beverage for improving immunity and a preparation method thereof.
The technical scheme adopted by the invention is as follows: a basidiomycete compound beverage for improving immunity is mainly prepared from the following raw materials in parts by mass:
80-480 parts of basidiomycete freeze-dried powder, 30-50 parts of red ginseng extract, 50-200 parts of acerola powder, 20-50 parts of rhizoma polygonati powder, 5-20 parts of fructo-oligosaccharide, 5-20 parts of pomegranate concentrated juice, 5-20 parts of carrot concentrated juice, 5-20 parts of noni pulp, 3-15 parts of gamma-aminobutyric acid, 6-30 parts of sour agent and 3-15 parts of flavoring agent.
Preferably, the beverage is mainly prepared from the following raw materials in parts by mass:
300 parts of basidiomycete freeze-dried powder, 32-45 parts of red ginseng extract, 75-183 parts of acerola powder, 22-40 parts of rhizoma polygonati powder, 8-16 parts of fructo-oligosaccharide, 8-16 parts of pomegranate concentrated juice, 8-16 parts of carrot concentrated juice, 8-16 parts of noni pulp, 5-12 parts of gamma-aminobutyric acid, 10-25 parts of sour additive and 6-10 parts of flavoring agent.
Preferably, the beverage is mainly prepared from the following raw materials in parts by mass:
280 parts of basidiomycete freeze-dried powder, 40 parts of red ginseng extract, 138 parts of acerola powder, 35 parts of fine yellow powder, 12 parts of fructo-oligosaccharide, 12 parts of pomegranate concentrated juice, 12 parts of carrot concentrated juice, 12 parts of noni fruit pulp, 8 parts of gamma-aminobutyric acid, 20 parts of sour agent and 8 parts of flavoring agent.
Preferably, the basidiomycete freeze-dried powder comprises basidiomycete mushroom hypha freeze-dried powder.
Preferably, the acidulant comprises malic acid and citric acid;
the ratio of the consumption of the malic acid to the consumption of the citric acid is 1-2: 1-3.
Preferably, the malic acid comprises DL-malic acid.
DL-malic acid, chinese alias: DL-malic acid. Colorless crystals or white crystalline powder, no odor or slightly peculiar odor, and has special pleasant sour taste. The malic acid is easy to dissolve in water, is internationally recognized as a safe food additive, is used as an acidulant, an antistaling agent and a pH value regulator, and has soft and long-lasting acidity which is 20 percent stronger than that of citric acid. Can be used for various foods, and is used in a proper amount according to production requirements. Can be used as food sour agent, antistaling agent and pH regulator. It has a mild and long-lasting sour taste, which is 20% stronger than citric acid. The malic acid is an important intermediate product of internal circulation of a human body and is easy to be absorbed by the human body, so that the malic acid serving as a food additive and functional food with excellent performance is widely applied to the fields of foods, cosmetics, medical and health-care products and the like.
Citric acid, an important organic acid, is also called citric acid, is a colorless crystal, usually contains a molecular crystal water, is odorless, has strong sour taste, and is easily soluble in water. White crystalline powder, odorless. Dissolved in water. Because citric acid has a mild, refreshing and sour taste, it is widely used in the manufacture of various beverages, carbonated drinks, wine, candies, snacks, biscuits, canned fruit juices, dairy products, and other foods. In all markets of organic acids, the market share of citric acid is more than 70%, and no sour agent capable of replacing citric acid exists at present. One molecule of crystalline aqueous citric acid is mainly used as an acidic flavoring agent for soft drinks, fruit juices, fruit jams, fruit candies, cans, etc., and also as an antioxidant for edible oils. Meanwhile, the sensory properties of the food are improved, the appetite is enhanced, and the digestion and absorption of calcium and phosphorus substances in the body are promoted. Anhydrous citric acid is used in large quantities in solid beverages. Salts of citric acid, such as calcium citrate and ferric citrate, are fortifiers in certain food products that require the addition of calcium and ferric ions. Esters of citric acid such as triethyl citrate can be used as nontoxic plasticizer for making plastic film for food packaging, sour agent for beverage and food industry, and antiseptic.
Preferably, the flavouring agent comprises a food grade flavour.
A preparation method of a basidiomycete compound beverage for improving immunity comprises the steps of selecting basidiomycete freeze-dried powder, red ginseng extract, acerola cherry powder, fine yellow powder, fructo-oligosaccharide, red pomegranate concentrated juice, carrot concentrated juice, noni pulp, gamma-aminobutyric acid, a sour agent and a flavoring agent according to corresponding proportions, and adding a solvent into the mixture to be mixed uniformly to obtain a finished product.
Preferably, the solvent comprises water.
Preferably, the ratio of the dosage of the solvent to the total dosage of the basidiomycete freeze-dried powder, the red ginseng extract, the acerola powder, the fine yellow powder, the fructo-oligosaccharide, the red pomegranate condensed juice, the carrot condensed juice, the noni fruit pulp, the gamma-aminobutyric acid, the sour agent and the flavoring agent is 1-3: 2-5.
The invention has the beneficial effects that:
the invention provides a basidiomycete composite beverage for improving immunity, which takes cellular immunology as a scientific theoretical basis, is matched with basidiomycete freeze-dried powder with an immune activation effect, red ginseng extract with functions of invigorating primordial qi, recovering pulse, consolidating qi and blood, fine yellow powder with functions of strengthening defensive qi, moistening lung and promoting the secretion of saliva or body fluid and other traditional Chinese medicine extracts with corresponding effects, acerola powder, fructo-oligosaccharide, red pomegranate condensed juice, carrot condensed juice, noni pulp, gamma-aminobutyric acid, sour agent and flavoring agent which complement each other and are mutually fused, and a preparation which can quickly regulate and activate the activity of autoimmune cells from a cell level, regulate an immune system, improve immunity, resist tumors, resist viruses, reduce blood sugar, resist oxidation and is easy to absorb, strengthen physique and contribute to sleep is obtained. In the preparation process of the compound beverage, an advanced pharmaceutical grade BFS sterile filling production process and production equipment are adopted, and the activity and effectiveness of various effective active ingredients are ensured.
Detailed Description
The present invention is further illustrated below with reference to specific examples. It will be appreciated by those skilled in the art that the following examples, which are set forth to illustrate the present invention, are intended to be part of the present invention, but not to be construed as limiting the scope of the present invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention. The examples were carried out under the conventional conditions, unless otherwise specified. The reagents used are all conventional products which are commercially available.
Example 1:
a preparation method of a basidiomycete compound beverage for improving immunity comprises the steps of selecting 80 g of basidiomycete mushroom hypha freeze-dried powder, 30 g of red ginseng extract, 50 g of acerola powder, 20 g of rhizoma polygonati powder, 5 g of fructo-oligosaccharide, 5 g of red pomegranate concentrated juice, 5 g of carrot concentrated juice, 5 g of noni pulp, 3 g of gamma-aminobutyric acid, 3 g of DL-malic acid, 3 g of citric acid and 3 g of edible essence according to corresponding proportion, and adding 424 g of water to mix uniformly to obtain a finished product.
Example 2:
a preparation method of a basidiomycete compound beverage for improving immunity comprises the steps of selecting 480 g of basidiomycete mushroom hypha freeze-dried powder, 50 g of red ginseng extract, 200 g of acerola powder, 50 g of rhizoma polygonati powder, 20 g of fructo-oligosaccharide, 20 g of red pomegranate concentrated juice, 20 g of carrot concentrated juice, 20 g of noni pulp, 15 g of gamma-aminobutyric acid, 15 g of DL-malic acid, 15 g of citric acid and 15 g of edible essence according to corresponding proportion, and adding 1840 g of water to mix uniformly to obtain a finished product.
Example 3:
a preparation method of a basidiomycete compound beverage for improving immunity comprises the steps of selecting 120 g of basidiomycete mushroom hypha freeze-dried powder, 32 g of red ginseng extract, 75 g of acerola powder, 22 g of rhizoma polygonati powder, 8 g of fructo-oligosaccharide, 8 g of red pomegranate concentrated juice, 8 g of carrot concentrated juice, 8 g of noni pulp, 5 g of gamma-aminobutyric acid, 4 g of DL-malic acid, 6 g of citric acid and 6 g of edible essence according to corresponding proportion, adding 604 g of water, and uniformly mixing to obtain a finished product.
Example 4:
a preparation method of a basidiomycete compound beverage for improving immunity comprises the steps of selecting 300 g of basidiomycete mushroom hypha freeze-dried powder, 45 g of red ginseng extract, 183 g of acerola powder, 40 g of sealwort powder, 16 g of fructo-oligosaccharide, 16 g of pomegranate condensed juice, 16 g of carrot condensed juice, 16 g of noni fruit pulp, 12 g of gamma-aminobutyric acid, 10 g of DL-malic acid, 15 g of citric acid and 10 g of edible essence according to corresponding proportion, and adding 1358 g of water to mix uniformly to obtain a finished product.
Example 5:
a preparation method of a basidiomycete compound beverage for improving immunity comprises the steps of selecting 280 g of basidiomycete mushroom hypha freeze-dried powder, 40 g of red ginseng extract, 138 g of acerola powder, 35 g of rhizoma polygonati powder, 12 g of fructo-oligosaccharide, 12 g of red pomegranate concentrated juice, 12 g of carrot concentrated juice, 12 g of noni pulp, 8 g of gamma-aminobutyric acid, 10 g of DL-malic acid, 10 g of citric acid and 8 g of edible essence according to corresponding proportions, and adding 1358 g of water to mix uniformly to obtain a finished product.
Example 6:
a preparation method of a basidiomycete compound beverage for improving immunity comprises the steps of selecting 280 g of basidiomycete mushroom hypha freeze-dried powder, 40 g of red ginseng extract, 138 g of acerola powder, 35 g of rhizoma polygonati powder, 12 g of fructo-oligosaccharide, 12 g of red pomegranate concentrated juice, 12 g of carrot concentrated juice, 12 g of noni pulp, 8 g of gamma-aminobutyric acid, 8 g of DL-malic acid, 12 g of citric acid and 8 g of edible essence according to corresponding proportions, and adding 1358 g of water to mix uniformly to obtain a finished product.
A lyophilized powder of Basidiomycetes mushroom mycelium is a compound of polysaccharide, amino acids, lipids and minerals extracted from mycelium of various Basidiomycetes mushrooms by long-term large-scale culture in a jar. Wherein the composition contains acetylated-a-1, 4 glucan complex. The acetylated-a-1, 4 glucan compound is completely different from common mushroom medicinal health care products, mainly comprises partially acetylated alpha-glucan and has the molecular weight of 5000 Da. Most medicinal mushrooms are rich in beta-glucan and have a molecular weight of about one hundred thousand to million. The low molecular weight property makes the acetylated-a-glucan complex more readily absorbed by the human body. This is the only acetylated-a-glucan complex that has been demonstrated to date worldwide for its mechanism of action and efficacy. The product was developed in 1987 with the university of tokyo and was shown to contribute to the enhancement of the human autoimmune surveillance function by inducing the immune system. Over 70 leading research institutions confirm that the product is safe and reliable, has no side effect and improves the clinical effects of organism immunity, tumor resistance and infection resistance. The product is used for more than 20 years in more than 20 countries, and is a unique food raw material for preventing and treating malignant tumor designated by Japan Kadsura. A study at Yale university found that AHCC simultaneously enhanced the immune function of CD4+, CD8+ T cells. After taking the product for 4 weeks, the number of CD4+ and CD8+ T cells is increased, and the yield of the cytokine IFN-gamma of CD4+ cells is greatly and continuously increased. The activity of the cells is obviously increased; effectively improve the self-healing force of the organism. Is selected from Japan.
The red ginseng is prepared by processing ginseng through the procedures of soaking, cleaning, sorting, steaming, airing, drying and the like, and the red ginseng has sweet, slightly bitter and warm taste and is sweet in taste, mild in taste and warm in taste and suitable for spleen, lung and heart meridians because of chemical reaction caused by heat treatment in the steaming process; the red ginseng has the characteristic of strong efficacy; ginsenoside has antiaging effect; the ginsenoside has the anti-fatigue effect on the ginseng by the effects of resisting oxidation, regulating immunity, regulating nervous system, influencing cell cycle regulation factor, aging gene expression and the like; the ginseng can play a role in resisting fatigue by removing free radicals and increasing the activity of superoxide dismutase (SOD); the plant polysaccharide in the ginseng has wide biological activity and has obvious effects on the aspects of immunoregulation, tumor resistance, virus resistance, blood sugar reduction, oxidation resistance and the like. Selected from vinblastine and artificially planted products with the age of 5 years and less than 5 years.
Acerola cherry powder with high VC content and natural VC source; the vitamin C has the advantage of neutralizing the endotoxin in cells, so the vitamin C not only can prevent and treat general infectious diseases, but also has better treatment effect on serious infectious diseases such as toxic shock and the like; leukocytes have high vitamin C concentrations that are reduced during stress and infection by counteracting oxidative reactions, promoting normal function of the immune system; vitamin C is a cofactor involved in the enzymatic reactions of collagen biosynthesis. The collagen accounts for one fourth of the protein in the human body and forms the main protein of skin, bones, teeth and connective tissues, and the VC can promote the normal formation of the collagen and also has the promoting effect on the normal functions of the bones, the teeth, the cartilage, the gingival skin and blood vessels; vitamin C is an accessory factor for catecholamine biosynthesis (especially the process of converting dopamine into norepinephrine), has a promoting effect on the normal function of the nervous system, and has a promoting effect on the normal psychological function; fatigue and weakness are among the symptoms of vitamin C deficiency, which contributes to normal energy metabolism, and vitamin C helps to relieve drowsiness and fatigue; can activate the naturally-occurring Nrf2 antioxidant pathway in organism cells, increase the levels of intracellular glutathione GSH-Px) and superoxide dismutase (SOD), promote the repair of damaged DNA, protein and lipid in cells, and repair damaged cells. Selected from France.
The pomegranate condensed juice and the pomegranate fruit contain 10 kinds of vitamins and mineral substances such as vitamin C, pomegranate polyphenol and anthocyanin substances, have good effects of expelling toxin and resisting oxidation, can balance hormones, and can regulate female estrogen level and endocrine disorder in physiological period.
Gamma-aminobutyric acid is an important inhibitory neurotransmitter in the central nervous system, can promote the activation of the brain, strengthen the brain, improve intelligence, resist epilepsy, beautify and moisten the skin, delay the aging function of the brain, supplement the inhibitory neurotransmitter of a human body and have good effect of reducing blood pressure. Promoting kidney function improvement and protection. Inhibiting fatty liver and obesity, and activating liver function. The daily supplement of trace gamma aminobutyric acid is beneficial to relieving the cardio-cerebral blood pressure, can promote the balance of amino acid metabolism in a human body and regulate the immune function. Has effects in tranquilizing nerve, relieving anxiety, and promoting sleep.
Noni pulp, a large amount of Xeronine contained in noni, can help repair body injury, metabolize toxin, and enhance physique; morinda citrifolia contains abundant serotonin and 7-hydroxy-6-methylcoumarin, and scientists have proved that it can moisten pineal body to secrete melatonin and has antihistaminic function. The pineal gland is the main gland for monitoring the operation of all glands, the hormone produced by the pineal gland is called melatonin, the melatonin affects every part of the body, the pineal gland is a purely natural sleeping substance and directly affects the growth, development and aging of the body, and when the melatonin secretion is reduced, the aging phenomenon begins to appear; the tannin component and various active polysaccharide substances of noni can enhance immunity, eliminate cancer cells and eliminate deposited toxins in vivo, and is helpful for preventing immune dysfunction and preventing; 2.8 times of noni vitamin C and 1.1 times of grape seed, has strong oxidation resistance, is helpful for body to resist harmful free radicals, and enhances physical ability.
The carrot concentrated juice contains vitamin A and beta-carotene, the molecular structure of the carotene is equivalent to 2 molecules of vitamin A, after entering an organism, the carotene passes through the action of enzyme in liver and small intestinal mucosa, wherein 50 percent of the carotene is changed into the vitamin A, the carotene has the functions of tonifying liver and improving eyesight, has the capability of promoting the generation of photosensitive pigment in eyes, can prevent nyctalopia, enhances the color discrimination capability of the eyes, and can also reduce eye fatigue and eye dryness; lipid peroxidation and free radical production in the organism cause a decrease in cell function, thereby causing aging of the human body; the carotene can inhibit the peroxidation of lipid, thereby reducing the inhibition of the peroxide on the immune function; it can also eliminate redundant free radicals in vivo and delay aging; the carrot is rich in vitamins, and can stimulate the metabolism of the skin and promote blood circulation, so that the skin is tender and smooth.
The fructo-oligosaccharide belongs to prebiotics, is water-soluble dietary fiber, improves the intestinal micro-ecological environment and strengthens the physique.
The rhizoma Polygonati powder has effects of invigorating qi, nourishing yin, invigorating spleen, moistening lung, invigorating kidney, improving memory, delaying aging, scavenging free radicals, reducing blood pressure, blood lipid, and inhibiting bacteria.
The finished product prepared by the method can be filtered in the actual production process, so that the beverage has corresponding fineness.
In the actual operation process of all the embodiments, the selected blending device comprises a three-dimensional motion mixer, stainless steel materials with specification models of SYH-30 and SYH-1000, and manufacturers: jiangyin and Rong mechanical Co. The selection of the stirring device is not limited to the above, and all devices which can complete the corresponding stirring work and have no influence on raw materials belong to the protection scope of the invention.
In the practical operation process of all the above embodiments, the selected filtering device comprises a microporous membrane filter, a stainless steel material, and the style: tubular, manufacturer: sitepu filtration equipment, Inc., New county. The selection of the filtering device is not limited to the above, and all devices which can complete the corresponding filtering work and have no influence on raw materials belong to the protection scope of the invention.
Examples of the experiments
The basidiomycete composite beverage is evaluated for sensory flavor, taste and stability. And (3) evaluating the sensory flavor, the mouthfeel and the color of the product of the beverage, and carrying out sensory test on the finished product by taking each embodiment as an experimental object. The number of test persons was 20. Tasting mode: tasting the samples in different examples in an anonymous scoring mode, separately scoring the flavor, the taste and the color of the products of the samples in different examples, wherein each test item is 10-point full score, and taking the average value, wherein the higher the average value is, the better the effect is.
TABLE 1 Basidiomycetes composite beverage flavor, taste and fineness test table
Index (I) | Example 1 | Example 2 | Example 3 | Example 4 | Example 5 | Example 6 |
Flavor (I) and flavor (II) | 8 | 8 | 8 | 9 | 9 | 9 |
Taste of the product | 8 | 8 | 9 | 9 | 9 | 9 |
Note: the above numbers represent the mean of the items. Wherein, the flavor: 8: the fruit taste is lighter; 9: the fruit taste is stronger. The mouthfeel is as follows: 8: smoothing; 9: the silk is smooth.
The results in table 1 show that the flavor and mouthfeel of the basidiomycete composite beverage in each example were optimal in examples 5, 6, 7 and 8.
Meanwhile, after all the experimental subjects take the finished products prepared by all the embodiments, the mental states of the experimental subjects obviously show the phenomena of full energy and high overall life and working efficiency.
The invention provides a basidiomycete composite beverage for improving immunity, which takes cellular immunology as a scientific theoretical basis, is matched with basidiomycete freeze-dried powder with an immune activation effect, red ginseng extract with functions of invigorating primordial qi, recovering pulse, consolidating qi and blood, fine yellow powder with functions of strengthening defensive qi, moistening lung and promoting the secretion of saliva or body fluid and other traditional Chinese medicine extracts with corresponding effects, acerola powder, fructo-oligosaccharide, red pomegranate condensed juice, carrot condensed juice, noni pulp, gamma-aminobutyric acid, sour agent and flavoring agent which complement each other and are mutually fused, and a preparation which can quickly regulate and activate the activity of autoimmune cells from a cell level, regulate an immune system, improve immunity, resist tumors, resist viruses, reduce blood sugar, resist oxidation and is easy to absorb, strengthen physique and contribute to sleep is obtained. In the preparation process of the compound beverage, an advanced pharmaceutical grade BFS sterile filling production process and production equipment are adopted, and the activity and effectiveness of various effective active ingredients are ensured.
While particular embodiments of the present invention have been illustrated and described, it will be appreciated that the present invention is not limited to the above-described alternative embodiments, and that various other forms of product may be devised by anyone in light of the present invention. The foregoing detailed description should not be construed as limiting the scope of the invention, and it will be understood by those skilled in the art that modifications may be made to the technical solutions described in the foregoing embodiments, or that equivalent substitutions may be made to some or all of the technical features thereof, without departing from the spirit and scope of the invention, and that these modifications or substitutions may not substantially depart from the essence of the corresponding technical solutions.
Claims (10)
1. A basidiomycete compound beverage for improving immunity is characterized by being prepared from the following raw materials in parts by mass:
80-480 parts of basidiomycete freeze-dried powder, 30-50 parts of red ginseng extract, 50-200 parts of acerola powder, 20-50 parts of rhizoma polygonati powder, 5-20 parts of fructo-oligosaccharide, 5-20 parts of pomegranate concentrated juice, 5-20 parts of carrot concentrated juice, 5-20 parts of noni pulp, 3-15 parts of gamma-aminobutyric acid, 6-30 parts of sour agent and 3-15 parts of flavoring agent.
2. The basidiomycete compound beverage for improving immunity according to claim 1, which is characterized in that the beverage is mainly prepared from the following raw materials in parts by mass:
300 parts of basidiomycete freeze-dried powder, 32-45 parts of red ginseng extract, 75-183 parts of acerola powder, 22-40 parts of rhizoma polygonati powder, 8-16 parts of fructo-oligosaccharide, 8-16 parts of pomegranate concentrated juice, 8-16 parts of carrot concentrated juice, 8-16 parts of noni pulp, 5-12 parts of gamma-aminobutyric acid, 10-25 parts of sour additive and 6-10 parts of flavoring agent.
3. The basidiomycete compound beverage for improving immunity according to claim 2, which is characterized in that the beverage is mainly prepared from the following raw materials in parts by mass:
280 parts of basidiomycete freeze-dried powder, 40 parts of red ginseng extract, 138 parts of acerola powder, 35 parts of fine yellow powder, 12 parts of fructo-oligosaccharide, 12 parts of pomegranate concentrated juice, 12 parts of carrot concentrated juice, 12 parts of noni fruit pulp, 8 parts of gamma-aminobutyric acid, 20 parts of sour agent and 8 parts of flavoring agent.
4. A basidiomycete compound beverage for improving immunity according to any one of claims 1 to 3, wherein the basidiomycete freeze-dried powder comprises basidiomycete mushroom hypha freeze-dried powder.
5. The basidiomycete compound drink for improving immunity according to any one of claims 1 to 3 in which the acidulant comprises malic acid and citric acid;
the ratio of the consumption of the malic acid to the consumption of the citric acid is 1-2: 1-3.
6. The Basidiomycetes composite drink for enhancing immunity according to claim 5, wherein said malic acid comprises DL-malic acid.
7. The basidiomycete composite drink for enhancing immunity according to any one of claims 1 to 3 in which the flavoring agent includes a food grade flavor.
8. The method for preparing the basidiomycete composite beverage for improving immunity according to claim 7, wherein the preparation method comprises the steps of selecting the basidiomycete freeze-dried powder, the red ginseng extract, the acerola powder, the fine yellow powder, the fructo-oligosaccharide, the red pomegranate condensed juice, the carrot condensed juice, the noni pulp, the gamma-aminobutyric acid, the sour agent and the flavoring agent according to corresponding proportions, adding the solvents and mixing uniformly to obtain a finished product.
9. The method for preparing the basidiomycete composite beverage for improving immunity according to claim 8, wherein the solvent includes water.
10. The method for preparing the basidiomycete compound beverage for improving immunity according to claim 8, wherein the ratio of the amount of the solvent to the total amount of the basidiomycete freeze-dried powder, red ginseng extract, acerola powder, yellow essence powder, fructo-oligosaccharide, red pomegranate condensed juice, carrot condensed juice, noni pulp, gamma-aminobutyric acid, sour agent and flavoring agent is 1-3: 2-5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011458352.3A CN112602861A (en) | 2020-12-10 | 2020-12-10 | Basidiomycetes composite beverage for improving immunity and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011458352.3A CN112602861A (en) | 2020-12-10 | 2020-12-10 | Basidiomycetes composite beverage for improving immunity and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112602861A true CN112602861A (en) | 2021-04-06 |
Family
ID=75233402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011458352.3A Pending CN112602861A (en) | 2020-12-10 | 2020-12-10 | Basidiomycetes composite beverage for improving immunity and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112602861A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113208023A (en) * | 2021-05-22 | 2021-08-06 | 厦门市燕之屋丝浓食品有限公司 | Sleep-aiding cubilose beverage and preparation method thereof |
CN115474660A (en) * | 2021-05-31 | 2022-12-16 | 海南三圣堂生物科技有限公司 | Anti-aging sleep-aiding noni enzyme formula and preparation method thereof |
CN116114871A (en) * | 2023-01-31 | 2023-05-16 | 山东健奕宏生物制药有限公司 | Chinese health-preserving composition for enhancing immunity and preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109730232A (en) * | 2019-03-19 | 2019-05-10 | 达威控股有限公司 | A kind of face beautifying and nourishing drink and preparation method thereof |
CN111616364A (en) * | 2020-07-03 | 2020-09-04 | 深圳市灵季文化传播有限公司 | Red ginseng and donkey-hide gelatin beverage and application thereof in health-care beverage |
-
2020
- 2020-12-10 CN CN202011458352.3A patent/CN112602861A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109730232A (en) * | 2019-03-19 | 2019-05-10 | 达威控股有限公司 | A kind of face beautifying and nourishing drink and preparation method thereof |
CN111616364A (en) * | 2020-07-03 | 2020-09-04 | 深圳市灵季文化传播有限公司 | Red ginseng and donkey-hide gelatin beverage and application thereof in health-care beverage |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113208023A (en) * | 2021-05-22 | 2021-08-06 | 厦门市燕之屋丝浓食品有限公司 | Sleep-aiding cubilose beverage and preparation method thereof |
CN115474660A (en) * | 2021-05-31 | 2022-12-16 | 海南三圣堂生物科技有限公司 | Anti-aging sleep-aiding noni enzyme formula and preparation method thereof |
CN116114871A (en) * | 2023-01-31 | 2023-05-16 | 山东健奕宏生物制药有限公司 | Chinese health-preserving composition for enhancing immunity and preparation method and application thereof |
CN116114871B (en) * | 2023-01-31 | 2023-09-22 | 浙江吉美食品科技有限公司 | Chinese health-preserving composition for enhancing immunity and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112602861A (en) | Basidiomycetes composite beverage for improving immunity and preparation method thereof | |
KR101541516B1 (en) | Mathod Manufacturing lON Mineral Using Silk worm, Muberry leaf, and Muberry twig And Health Drink Manufactured by this | |
KR100902539B1 (en) | Functional drink comprising abalone extract and the preparation method of thereof | |
CN105379849A (en) | Soybean milk capable of enhancing immunity | |
CN106266229B (en) | Enzyme with blood replenishing effect and preparation method thereof | |
CN111616364A (en) | Red ginseng and donkey-hide gelatin beverage and application thereof in health-care beverage | |
CN102805170A (en) | Black tea fungus beverage as well as preparation technology and application thereof | |
CN111374297A (en) | Compound salt and preparation method thereof | |
CN106689948B (en) | Collagen composite linolenic acid beverage and preparation method thereof | |
CN106635719A (en) | Passion fruit vinegar and preparation method thereof | |
CN106617049A (en) | Propolis healthcare product with moringa oleifera leaf extract and method for preparing propolis healthcare product | |
CN107557204B (en) | Mixed brewed litchi rose wine and preparation method thereof | |
CN105029553A (en) | Fruit juice-egg-calcium traditional Chinese medicine health beverage and preparation method thereof | |
KR101716297B1 (en) | Method drinks for prevent a metabolic syndrome that made by Hericium erinaceus extracts containing crude drugs extracts. | |
CN107557254B (en) | Litchi rose wine, preparation method and application of litchi rose wine in qi and blood tonifying and oxidation resistance | |
CN104397792A (en) | Making method for Pleurotus eryngii ginger juice beverage | |
KR100977849B1 (en) | Composition for Juice of Fruits and Vegetables Containing Kimchi's Lactic Acid Bacterias | |
CN109527577A (en) | A kind of composition with sobering up and liver protecting functions | |
CN114938835A (en) | Dihydroquercetin SOD (superoxide dismutase) collagen tripeptide beverage formula | |
CN108187032A (en) | Cordyceps sinensis collagen peptide piece | |
KR101058422B1 (en) | Herbal dietary supplement and its manufacturing method | |
CN104726320B (en) | A kind of fig honey vinegar and preparation method | |
KR20070047396A (en) | A functional beverage using hericium erinaceus extracts and manufacturing process of the same | |
CN113841884A (en) | Formula of instant meal replacement powder for improving nutrient metabolism and preparation method thereof | |
CN114788556A (en) | Alcohol-dispelling medlar tea vinegar beverage and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210406 |